Biotech Stock Blasts Higher After Upbeat Trial Data

2 analysts lifted their price targets after the update

Deputy Editor
Jun 28, 2022 at 10:27 AM
facebook twitter linkedin


Kezar Life Sciences Inc (NASDAQ:KZR) is skyrocketing today, up 84.1% at $10.55, after positive results from a mid-stage study of its kidney disorder drug, zetomipzomib. Following the data, Wells Fargo raised its price target to $17 from $13, while JonesTrading upped its price objective to $20 from $17. 

Today's pop has the equity recovering a good portion of its early-May bear gap, as well as removing it further from its mid-June lows. Still, the stock's 100-day moving average lingers just overhead as potential pressure. 

Analysts are wholeheartedly bullish on KZR, making today's bull notes more noteworthy. All five firms in coverage carry a "strong buy" rating, and the 12-month consensus price target of $19 is an 87% premium to current levels.  

Meanwhile, short interest has been building, up 19.7% during the most recent two-week reporting period. Now, the 4.30 million shares sold short account for 9.3% of the stock's available float. 

The equity's usually quiet options pits are bursting with activity today. So far, 7,591 calls and 3,231 puts have exchanged hands, which is 150 times what is typically seen at this point. Most popular is the July 12.50 call, followed by the October 21 call, with positions being opened at the latter.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

 


 


 
Special Offers from Schaeffer's Trading Partners